MidwestPop. 5.9M

GLP-1 Coverage & Costs in Wisconsin (2026)

$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm Wisconsin at intake.

The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.

Medicaid: covered as of January 2026 (KFF)
Eduard Cristea
Eduard Cristea
Published: |Updated:

Wisconsin Medicaid Coverage for GLP-1

Medicaid: covered as of January 2026 (KFF)

KFF's map lists Wisconsin among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.

Wisconsin Medicaid GLP-1 Prescriptions in 2025

Prescriptions paid

302,633

Rank of 51

#8

Medicaid paid, before rebates

$320.7 million

Most-filled product

Zepbound

Wisconsin Medicaid paid for 302,633 GLP-1 prescriptions in 2025, 2.7% of the 11.26 million paid nationally and number 8 of 51 (50 states and DC). It reimbursed pharmacies $320.7 million before manufacturer rebates, about $1,060 per prescription, and the most-filled product was Zepbound. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 177,176 of those prescriptions (58.5%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.

From 2021 to 2025, Wisconsin Medicaid GLP-1 prescriptions went from 64,023 to 302,633, 4.7 times the 2021 count. From 2024 to 2025 the count rose by 100,905.

2021

64,023

2022

92,342

2023

154,913

2024

201,728

2025

302,633

ProductWI Medicaid prescriptions, 2025Share
Zepbound110,68836.6%
Trulicity91,12230.1%
Wegovy65,11421.5%
Ozempic22,0457.3%
Mounjaro7,4322.5%
Liraglutide (generic)3,2671.1%
Saxenda1,3740.5%
Victoza1,1790.4%
Rybelsus3090.1%
Byetta76under 0.1%
Exenatide (generic)27under 0.1%

Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.

Wisconsin Employee Plan and Insurer GLP-1 Rules

Wisconsin Group Health Insurance Program (ETF)

Does not cover GLP-1s for weight loss

Wisconsin's state Group Health Insurance Program has excluded weight-loss drugs. In March 2026 the Group Insurance Board approved covering GLP-1 anti-obesity medications for non-Medicare members from January 1, 2027, with a $200 copay.

  • ETF's August 2024 Board presentation says weight-loss drugs have always been excluded from the program.

    “Weight-loss drugs have always been excluded from the Group Health Insurance Program.”

    Source: Wisconsin Department of Employee Trust Funds. Read October 29, 2026.

  • ETF's March 16, 2026 news item says the Board approved anti-obesity medication coverage for non-Medicare members starting January 1, 2027.

    “In addition, the Board approved coverage of AOMs at a separate cost-sharing level for non-Medicare members, effective January 1, 2027.”

    Source: Wisconsin Department of Employee Trust Funds. Read October 29, 2026.

  • Members will pay a $200 copay for these drugs.

    “Members will have a $200 copay for these weight-loss drugs.”

    Source: Wisconsin Department of Employee Trust Funds. Read October 29, 2026.

We have no Wisconsininsurer policy on record yet. Most commercial plans decide GLP-1 coverage plan by plan, so the employer's choice matters as much as the insurer.

Comparing self-pay programs in Wisconsin?

2-minute quiz: filter by budget and medication preference.

Take the quiz →

Telehealth Programs to Check for Wisconsin

We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Wisconsin. The rest record a state count without naming the states, so confirm Wisconsin with the program at intake before you pay.

What Programs' Own Pages Say About Wisconsin

8 of the 8 programs whose own pages name the states they serve include Wisconsin: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.

Trimi's state table lists Wisconsin as served through the Arora Health network. Visit format there: Online evaluation through the Arora Health network. The telehealth law it cites for Wisconsin is Wis. Admin. Code § Med 24.03 and § Med 24.07. That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.

Programs on Our List, in Published Order

Compounded GLP-1 care with one-month and prepaid plans

Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support

Affordable compounded semaglutide from $119/mo with free shipping and health coaching

From $119/mo semaglutide, from $185/mo tirzepatide, 12-month planCompounded Semaglutide, Compounded TirzepatideAll 50 States

Personalized GLP-1 weight loss with licensed providers and nationwide coverage

45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.

Estimated GLP-1 Costs in Wisconsin

Best Value

Telehealth (Compounded)

$79 to $399/mo

Recorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.

Wegovy

Brand prices with and without insurance.

Zepbound

List, LillyDirect and savings card prices.

No insurance

Self-pay GLP-1 options without coverage.

The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.

Medicare Part D GLP-1 Claims in Wisconsin, 2024

Wisconsin prescribers wrote 371,741 Medicare Part D GLP-1 claims in 2024, number 21 of 51, with $460.7 million in gross drug cost before rebates. Ozempic led with 157,323 claims for 29,666 enrollees. Wegovy had 3,218 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.

ProductWI Part D claimsEnrollees
Ozempic157,32329,666
Trulicity118,72820,313
Mounjaro66,32211,917
Rybelsus15,9903,886
Victoza5,219Not given
Bydureon Bcise3,865794
Wegovy3,218843
Liraglutide731320
Byetta34587

Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.

Now Live — Launched July 1, 2026

Medicare GLP-1 Bridge Program in Wisconsin

The Bridge is national, so the rules are the same in Wisconsin as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.

Patient Cost

$50/mo

Launch Date

July 1, 2026

Runs Through

Dec 31, 2027

Read the Full Medicare Guide

How Wisconsin Compares to Other Midwest States

Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Wisconsin and its neighbors in the Midwest are recorded:

StateMedicaid and GLP-1s for obesityMedicaid GLP-1 Rx, 2025
Wisconsin (this page)Covered, January 2026 (KFF)302,633
IllinoisNot covered288,470
IndianaNot covered190,013
IowaNot covered88,518
KansasCovered, January 2026 (KFF)50,850
MichiganCovered, January 2026 (KFF)607,982
MinnesotaCovered, January 2026 (KFF)230,594

Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.

KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.

GLP-1 Guides for Wisconsin Cities

If Your Insurance Denies GLP-1 Coverage in Wisconsin

Commercial plans offer an internal appeal, then external review; Wisconsin Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.

How to Check Your Specific Plan in Wisconsin

  • Wisconsin Medicaid: Medicaid: covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
  • State employees: Wisconsin Group Health Insurance Program (ETF), does not cover glp-1s for weight loss per the documents cited above. Confirm with the plan before you fill a prescription.
  • Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.

Find the Right GLP-1 Provider in Wisconsin

Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in Wisconsin.

Frequently Asked Questions — Wisconsin

Does Wisconsin Medicaid cover GLP-1 medications for weight loss?
KFF's map lists Wisconsin among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. Contact your Medicaid plan for its drug list and prior authorization requirements.
How many GLP-1 prescriptions did Wisconsin Medicaid pay for in 2025?
Wisconsin Medicaid paid for 302,633 GLP-1 prescriptions in 2025, 2.7% of the 11.26 million paid nationally and number 8 of 51 (50 states and DC). It reimbursed pharmacies $320.7 million before manufacturer rebates, about $1,060 per prescription, and the most-filled product was Zepbound. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 177,176 of those prescriptions (58.5%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it. From 2021 to 2025, Wisconsin Medicaid GLP-1 prescriptions went from 64,023 to 302,633, 4.7 times the 2021 count. From 2024 to 2025 the count rose by 100,905. Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026).
How many Medicare Part D GLP-1 claims were there in Wisconsin in 2024?
Wisconsin prescribers wrote 371,741 Medicare Part D GLP-1 claims in 2024, number 21 of 51, with $460.7 million in gross drug cost before rebates. Ozempic led with 157,323 claims for 29,666 enrollees. Wegovy had 3,218 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses. Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026).
Does the Wisconsin state employee health plan cover GLP-1s for weight loss?
Wisconsin Group Health Insurance Program (ETF): does not cover glp-1s for weight loss. Wisconsin's state Group Health Insurance Program has excluded weight-loss drugs. In March 2026 the Group Insurance Board approved covering GLP-1 anti-obesity medications for non-Medicare members from January 1, 2027, with a $200 copay. Source: Wisconsin Department of Employee Trust Funds, read October 29, 2026.
What is the cheapest way to get GLP-1 medication in Wisconsin?
The lowest monthly-plan price we have recorded among programs on this page is $79/month (Embody, compounded semaglutide, monthly plan). Embody lists 48 states and our records do not name them, so confirm Wisconsin at intake. Medicare Part D enrollees who qualify can get Foundayo, Wegovy or Zepbound KwikPen for $50/month through the Bridge.
Which online GLP-1 programs serve Wisconsin?
8 of the 8 programs whose own pages name the states they serve include Wisconsin: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. For the other programs on this page, confirm Wisconsin at intake before you pay.
Does Medicare cover GLP-1s in Wisconsin?
Yes for eligible Part D enrollees in Wisconsin: $50/month through the Medicare GLP-1 Bridge, July 1, 2026 to December 31, 2027, under the BMI rules in the Medicare section above.

Ready to start?

Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.

Embody (paid link)

from $49/mo, 12-month plan

Visit Embody